# Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

> **NCT01743404** · PHASE2 · UNKNOWN · sponsor: **Institute for Atherosclerosis Research, Russia** · enrollment: 300 (estimated)

## Conditions studied

- Carotid Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Inflaminat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01743404
- **Lead sponsor:** Institute for Atherosclerosis Research, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2012-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743404, "Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01743404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*